Eisai Co Financials

Eisai Co Stock Summary

Eisai Co competes with Leef Brands, and Eisai. It offers Aricept for the treatment of alzheimers diseasedementia with Lewy bodies Methycobal for the treatment of peripheral neuropathy and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan. Eisai operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 11322 people.

Eisai Co Key Financial Ratios

There are many critical financial ratios that Eisai Co's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Eisai Co reports annually and quarterly.

Eisai Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Eisai Co's current stock value. Our valuation model uses many indicators to compare Eisai Co value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eisai Co competition to find correlations between indicators driving Eisai Co's intrinsic value. More Info.Eisai Co is rated # 2 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers reporting about  0.09  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Eisai Co is roughly  11.29 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eisai Co's earnings, one of the primary drivers of an investment's value.

Eisai Co Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Eisai Co help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Eisai Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eisai Co based on widely used predictive technical indicators. In general, we focus on analyzing Eisai Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eisai Co's daily price indicators and compare them against related drivers.

When running Eisai Co's price analysis, check to measure Eisai Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eisai Co is operating at the current time. Most of Eisai Co's value examination focuses on studying past and present price action to predict the probability of Eisai Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eisai Co's price. Additionally, you may evaluate how the addition of Eisai Co to your portfolios can decrease your overall portfolio volatility.